These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 21549765)

  • 1. Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice.
    Umathe SN; Manna SS; Jain NS
    Behav Brain Res; 2011 Sep; 223(1):125-34. PubMed ID: 21549765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoid analogues exacerbate marble-burying behavior in mice via TRPV1 receptor.
    Umathe SN; Manna SS; Jain NS
    Neuropharmacology; 2012 Apr; 62(5-6):2024-33. PubMed ID: 22248639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
    Haller VL; Stevens DL; Welch SP
    Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracetamol potentiates the antidepressant-like and anticompulsive-like effects of fluoxetine.
    Manna SS; Umathe SN
    Behav Pharmacol; 2015 Apr; 26(3):268-81. PubMed ID: 25340977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of endocannabinoid transmission induces antidepressant-like effects in rats.
    Adamczyk P; Gołda A; McCreary AC; Filip M; Przegaliński E
    J Physiol Pharmacol; 2008 Jun; 59(2):217-28. PubMed ID: 18622041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors.
    Umathe SN; Manna SS; Utturwar KS; Jain NS
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1191-9. PubMed ID: 19580839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of subthalamic neuron activity by endocannabinoids.
    Morera-Herreras T; Ruiz-Ortega JA; Taupignon A; Baufreton J; Manuel I; Rodriguez-Puertas R; Ugedo L
    Synapse; 2010 Sep; 64(9):682-98. PubMed ID: 20336631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anandamide modulates the neuroendocrine responses induced by extracellular volume expansion.
    Ruginsk SG; Uchoa ET; Elias LL; Antunes-Rodrigues J
    Clin Exp Pharmacol Physiol; 2013 Oct; 40(10):698-705. PubMed ID: 23875874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice.
    Gomes FV; Casarotto PC; Resstel LB; Guimarães FS
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):434-8. PubMed ID: 21111767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between endocannabinoid and serotonergic systems in mood disorders caused by nicotine withdrawal.
    Mannucci C; Navarra M; Pieratti A; Russo GA; Caputi AP; Calapai G
    Nicotine Tob Res; 2011 Apr; 13(4):239-47. PubMed ID: 21324836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoid modulation of male rat sexual behavior.
    Gorzalka BB; Morrish AC; Hill MN
    Psychopharmacology (Berl); 2008 Jul; 198(4):479-86. PubMed ID: 17694389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A possible participation of transient receptor potential vanilloid type 1 channels in the antidepressant effect of fluoxetine.
    Manna SS; Umathe SN
    Eur J Pharmacol; 2012 Jun; 685(1-3):81-90. PubMed ID: 22542657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.
    Khasabova IA; Khasabov S; Paz J; Harding-Rose C; Simone DA; Seybold VS
    J Neurosci; 2012 May; 32(20):7091-101. PubMed ID: 22593077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys.
    Schindler CW; Scherma M; Redhi GH; Vadivel SK; Makriyannis A; Goldberg SR; Justinova Z
    Psychopharmacology (Berl); 2016 May; 233(10):1867-77. PubMed ID: 26803499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of acetaminophen in the mouse elevated plus-maze test.
    Zaitone SA; El-Wakeil AF; Abou-El-Ela SH
    Behav Pharmacol; 2012 Aug; 23(4):417-25. PubMed ID: 22750843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion.
    da Veiga MA; Fonseca Bloise F; Costa-E-Sousa RH; Souza LL; Almeida NA; Oliveira KJ; Pazos-Moura CC
    J Endocrinol; 2008 Nov; 199(2):235-42. PubMed ID: 18755884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
    Desroches J; Charron S; Bouchard JF; Beaulieu P
    Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of endocannabinoid neurotransmission modulators on brain stimulation reward.
    Vlachou S; Nomikos GG; Panagis G
    Psychopharmacology (Berl); 2006 Oct; 188(3):293-305. PubMed ID: 16953388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses.
    Batista LA; Bastos JR; Moreira FA
    J Psychopharmacol; 2015 Mar; 29(3):335-43. PubMed ID: 25601395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors.
    Sartim AG; Guimarães FS; Joca SR
    Behav Brain Res; 2016 Apr; 303():218-27. PubMed ID: 26801828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.